Their results echo a similar 2019 Australian study of 300 women, which also found a 'very promising' 50 per cent reduction in ...
Vyleesi (bremelanotide) and Addyi (flibanserin) can help treat female sexual interest/arousal disorder (FSIAD) in premenopausal people. The FDA has not approved Viagra for use in females.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results